Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
碩士 === 國立中興大學 === 獸醫學系 === 82 === The objective of this study is to prepare monoclonal antibodies (MAbs) against the hemolysin of Actinobacillus pleuropneumoniae (A.P.) serotype 1 (HylI). These MAbs were then used in the injection...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
1994
|
Online Access: | http://ndltd.ncl.edu.tw/handle/69512808151164258821 |
id |
ndltd-TW-082NCHU0541005 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-082NCHU05410052015-10-13T15:33:32Z http://ndltd.ncl.edu.tw/handle/69512808151164258821 Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae 胸膜肺炎放線桿菌溶血素單株抗體之製作 Liang, Judging 梁嘉君 碩士 國立中興大學 獸醫學系 82 The objective of this study is to prepare monoclonal antibodies (MAbs) against the hemolysin of Actinobacillus pleuropneumoniae (A.P.) serotype 1 (HylI). These MAbs were then used in the injection of mice, to assess their protection activity against A.P. challenge. The spleens of BALB/c mice had been immunized 4 times with purified HylI and showed very strong antibody response.These spleen cells were then fused with P3x myeloma cells. When screening test for specific antibodies production using the ELISA test, 24 out of 880 wells showed strong positive reactions. Subsequently 3 consecutive subclonings had established 9 strains of hybridoma with stable activities of MAbs secretion. Two strains among them with resist-hemolytic reactions injected mice. When comparing those immunized mice with those have been immunized by the bacteria, the survival ratio was 8:5 after the A.P. challenge. Whereas the contral groups (immunized with PBS) were killed after the challenge. Those challenge bacteria could be recovered from the lungs of dead mice. Chen, San Duo 陳三多 1994 學位論文 ; thesis 83 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立中興大學 === 獸醫學系 === 82 === The objective of this study is to prepare monoclonal
antibodies (MAbs) against the hemolysin of Actinobacillus
pleuropneumoniae (A.P.) serotype 1 (HylI). These MAbs were
then used in the injection of mice, to assess their
protection activity against A.P. challenge. The spleens of
BALB/c mice had been immunized 4 times with purified HylI
and showed very strong antibody response.These spleen cells
were then fused with P3x myeloma cells. When screening test
for specific antibodies production using the ELISA test, 24
out of 880 wells showed strong positive reactions. Subsequently
3 consecutive subclonings had established 9 strains of
hybridoma with stable activities of MAbs secretion. Two
strains among them with resist-hemolytic reactions
injected mice. When comparing those immunized mice with
those have been immunized by the bacteria, the survival
ratio was 8:5 after the A.P. challenge. Whereas the
contral groups (immunized with PBS) were killed after the
challenge. Those challenge bacteria could be recovered from
the lungs of dead mice.
|
author2 |
Chen, San Duo |
author_facet |
Chen, San Duo Liang, Judging 梁嘉君 |
author |
Liang, Judging 梁嘉君 |
spellingShingle |
Liang, Judging 梁嘉君 Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae |
author_sort |
Liang, Judging |
title |
Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae |
title_short |
Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae |
title_full |
Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae |
title_fullStr |
Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae |
title_full_unstemmed |
Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae |
title_sort |
monoclonal antibody preparation against the hemolysin of actinobacillus pleuropneumoniae |
publishDate |
1994 |
url |
http://ndltd.ncl.edu.tw/handle/69512808151164258821 |
work_keys_str_mv |
AT liangjudging monoclonalantibodypreparationagainstthehemolysinofactinobacilluspleuropneumoniae AT liángjiājūn monoclonalantibodypreparationagainstthehemolysinofactinobacilluspleuropneumoniae AT liangjudging xiōngmófèiyánfàngxiàngǎnjūnróngxuèsùdānzhūkàngtǐzhīzhìzuò AT liángjiājūn xiōngmófèiyánfàngxiàngǎnjūnróngxuèsùdānzhūkàngtǐzhīzhìzuò |
_version_ |
1717766668687507456 |